Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.

[1]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[2]  A. Bostom,et al.  Postmenopausal estrogen therapy and cardiovascular disease. , 1992, The New England journal of medicine.

[3]  B. Rosner,et al.  Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. , 1991, The New England journal of medicine.

[4]  S. Campbell,et al.  Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause , 1991, The Lancet.

[5]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[6]  D. Mirvis,et al.  Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. , 1990, Archives of internal medicine.

[7]  C. Christiansen,et al.  Influence of menopause on serum lipids and lipoproteins. , 1990, Maturitas.

[8]  K. Matthews,et al.  Menopause and Risk Factors for Coronary Heart Disease , 1989 .

[9]  J. O. Humphries,et al.  Risk factors and noncontraceptive estrogen use in women with and without coronary disease. , 1989, American heart journal.

[10]  B. Sherwin,et al.  A Prospective One-Year Study of Estrogen and Progestin in Postmenopausal Women: Effects on Clinical Symptoms and Lipoprotein Lipids , 1989, Obstetrics and gynecology.

[11]  R. Lobo,et al.  A randomized comparison of nonoral estradiol delivery in postmenopausal women. , 1988, American journal of obstetrics and gynecology.

[12]  B. Henderson,et al.  Estrogen replacement therapy and protection from acute myocardial infarction. , 1988, American journal of obstetrics and gynecology.

[13]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[14]  H. Judd.  Efficacy of transdermal estradiol. , 1987, American journal of obstetrics and gynecology.

[15]  V. Manninen,et al.  Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women. , 1987, Maturitas.

[16]  C. Fletcher,et al.  The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women. , 1986, Acta endocrinologica.

[17]  D. Meldrum,et al.  Biologic effects of transdermal estradiol , 1986, The New England journal of medicine.

[18]  R. Lobo,et al.  Comparison of Lipid and Androgen Levels After Conjugated Estrogen or Depo- Medroxyprogesterone Acetate Treatment in Postmenopausal Women , 1985, Obstetrics and Gynecology.

[19]  B. Guy-grand,et al.  Differential lipemic and hormonal responses to oral and parenteral 17 beta-estradiol in postmenopausal women. , 1983, American journal of obstetrics and gynecology.

[20]  U. Larsson‐cohn,et al.  Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women. , 1982, Acta endocrinologica.

[21]  E. Barrett-Connor,et al.  ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE Report from the Medications Working Group of the Lipid Research Clinics Program , 1979, The Lancet.

[22]  E. Vartiainen,et al.  NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMEN , 1978, The Lancet.

[23]  W. Kannel,et al.  Menopause and Coronary Heart Disease: The Framingham Study , 1978 .

[24]  G. Somers,et al.  MYOCARDIAL INFARCTION: A COMPLICATION OF VINCRISTINE TREATMENT? , 1976, The Lancet.

[25]  W. Kannel,et al.  Some atherogenic concomitants of menopause: The Framingham Study. , 1976, American journal of epidemiology.

[26]  S. Johansson,et al.  Letter: A radioimmunoassay for serum-alpha-fetoprotein based on commercial antisera. , 1974, Lancet.

[27]  G. Addison.  Letter: Serum-ferritin. , 1974, Lancet.

[28]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[29]  G. S. Boyd,et al.  Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. , 1959, Lancet.

[30]  C. Christiansen,et al.  Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. , 1987, American journal of obstetrics and gynecology.